Peter McLaughlin

402 papers receiving 17.5k citations

Peter McLaughlin's Hit Papers

Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project 2009 · 519 citations
5190+12+25Years since publication50010001.5k2.0k

Peers

Peter McLaughlin
Comparison fields: 5 of 192
  • Pathology and Forensic Medicine 10.3k
  • Genetics 4.7k
  • Oncology 6.0k
  • Hematology 1.5k
  • Neurology 1.9k
Replace Stanisław Krajewski with:
Stanisław Krajewski United States
Peter C. Nowell̀ United States
Albert de la Chapelle Finland
Charis Eng United States
Olivier Hermine France
Shigeo Nakamura Japan
Reiner Siebert Germany
Jeremy A. Squire Canada
Ramon Parsons United States
George A. Calin United States
Peter McLaughlin relative to Stanisław Krajewski United States Stanisław Krajewski's profile →
Citations per field
00.5×4.7×
Stanisław Krajewski · 1×
Citations per year

Countries citing papers authored by Peter McLaughlin

Since Specialization
Citations

This map shows the geographic impact of Peter McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter McLaughlin more than expected).

Fields of papers citing papers by Peter McLaughlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter McLaughlin. The network helps show where Peter McLaughlin may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter McLaughlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter McLaughlin Line = papers co-authored together Peter McLaughlin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 407 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
Hit paper breakdown →
19982158
2
Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-Treatment
Hit paper breakdown →
2000526
3
Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project
Hit paper breakdown →
2009519
4
Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)
Hit paper breakdown →
1988490
5 1998444
6 2004416
7 2005383
8 1994348
9 2001265
10 1996220
11 1998215
12 2008215
13 1987204
14 1993186
15 2003174
16 1992174
17 2010169
18 2008168
19 2010166
20 1984163

About Peter McLaughlin

Peter McLaughlin is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Neurology and Molecular Biology, having authored 407 papers that have together received 18.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (234 papers), Chronic Lymphocytic Leukemia Research (93 papers), Viral-associated cancers and disorders (63 papers), CNS Lymphoma Diagnosis and Treatment (50 papers), Acute Lymphoblastic Leukemia research (16 papers), Neurotransmitter Receptor Influence on Behavior (16 papers), Cannabis and Cannabinoid Research (15 papers) and Monoclonal and Polyclonal Antibodies Research (15 papers). The work is most often cited by research in Pathology and Forensic Medicine (10.3k citations), Genetics (4.7k citations), Oncology (6.0k citations), Hematology (1.5k citations) and Neurology (1.9k citations). Peter McLaughlin has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Fernando Cabanillas, Fredrick B. Hagemeister, Jorge Romaguera, Maria Alma Rodriguez, Anas Younes, F Swan, Barbara Pro, A.J. Grillo-López, Luis Fayad and Christine A. White. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Oncology, Cancer and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact